Skip to main content
SpringerLink
Log in

Venture capital shifts strategies, startups suffer

  • News
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

An Erratum to this article was published on 01 July 2009

This article has been updated

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1

Change history

  • 08 July 2009

    In the version of this article initially published, “GSK Ventures” should have read “GlaxoSmithKline’s SR One.” The error has been corrected in the HTML and PDF versions of the article.

Author information

Authors and Affiliations

  1. London

    Peter Mitchell

Authors
  1. Peter Mitchell
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mitchell, P. Venture capital shifts strategies, startups suffer. Nat Biotechnol 27, 103–104 (2009). https://doi.org/10.1038/nbt0209-103

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0209-103

  • Springer Nature America, Inc.

This article is cited by

Search

Navigation